Like rock posters, album art, and comix, blotter art played a crucial role in shaping the counterculture experience. The post...
VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF /...
NEW YORK and BERLIN, March 04, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
A groundbreaking study by Northwestern Medicine has unveiled the intricate processes that enable ketamine to produce both immediate and enduring antidepressant...
The company said its operations are funded through 2025. The post GH Research pushes forward with DMT trials, drug approvals appeared first on Green Market...
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”),...
NEW YORK, February 28, 2024–(BUSINESS WIRE)–Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (Cboe Canada:MMED), (the “Company” or “MindMed”), a...
SARASOTA, FL, Feb. 28, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...
The firm has a negative working capital of nearly $1 million. The post Psyence reports no revenue in Q4, but returns a profit appeared first on...
The psychoactive compound, MEAI, is dubbed a "binge mitigating agent." The post Clearmind trials new alcohol disorder fix appeared first on Green Market...
The growing market for vaporizers that offers portable, disposable and convenient delivery systems for DMT, psilocybin, 2C-B and other psychedelic substances. The...
TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“Revive” or the “Company”) announces that it has...
Clearmind Medicine Inc., a name synonymous with innovation in the pharmaceutical sector, recently marked a significant milestone in its journey towards...
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company...
Toronto, Ontario–(Newsfile Corp. – February 27, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or...
Enveric Biosciences (NASDAQ: ENVB) is selling one of its cancer-related patent portfolios for an undisclosed amount. Enveric said it plans to continue...